Показания к применению
ВИЧ в составе комбинированной терапии с др. антиретровирусными ЛС.
Действующее вещество:
FOSAMPRENAVIR FOSAMPRENAVIR CALCIUM
Описание препарата на английском
Lexiva is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV-1) infection in adults. The following points should be considered when initiating therapy with Lexiva plus ritonavir in protease inhibitor - experienced patients: - The protease inhibitor - experienced patient trial was not large enough to reach a definitive conclusion that Lexiva plus ritonavir and lopinavir/ritonavir are clinically equivalent. - Once - daily administration of Lexiva plus ritonvir is not recommended for adult proteaseinhibitor-experienced patients.
| Характеристики | |
| По рецепту | по рецепту |
| Срок годности | 36 мес. |
| Форма употребления | FILM COATED TABLETS |
Ссылка на сайт МинЗдрава Израиля: http://www.old.health.gov.il/units/pharmacy/trufot/PerutTrufa.asp?Reg_Number=131 85 31013 01&safa=e
Телзир